1American Thoracic Society, Infectious Disease Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and heahhcare-associated pneumonia [ J ]. Am J Reso Crit Care Med, 2005, 171 : 388-416.
3Zhao T, Liu Y, Cao B, et al. Prospective multicenter study of pathogen distributions in early-onset and late-onset hospital- acquired pneumonia in China[ J]. Antimicrob Agents Chemother, 2013, 57 : 6404-6405.
4Chung DR, Song JH, Kim SH, et al. High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumoniain Asia[J]. Am Respir Criti Care Med, 2011, 184: 1409-1417.
5Gastmeier P, Sohr D, Geffers C, et al. Early-and late-onset pneumonia: is this still a useful classification? [ J ]. Antimierob Agents Chemother, 2009, 53: 2714-2718.
6Ferrer M, Liapikou A, Valencia M, et al. Validation of the American Thoracic Society-Infectious Diseases Society of Americaguidelines for hospital-acquired pneumonia in the intensive care unit[Jl. Clin Infect Dis, 2010, 50: 945-952.
2Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med, 2002,165 : 867-903.
3Fagon JY, Chastre J, Hance A J, et al. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med, 1993,94:281-288.
4Rello J, Ollendorf DA, Oster G, et al. Epidemiology and outcomes of pneumonia in a large US database. Chest, 2002,122 : 2115-2121.
5Safdar N, Dezfulian C, Collard HR, et al. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med, 2005, 33 : 2184-2193.
6Luna CM, Vujacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest, 1997, 111: 676-685.
7Horan TC, Gaynes RP. Surveillance of nosocomial infections. In : Hospital Epidemiology and Infection Control, 3rd ed. Mayhall CG, editor. Philadelphia: Lippincott Williams & Wilkins, 2004: 1659-1702.
8Clinical and Laboratory Standards Institute. Performance standards for antimicrohial susceptibility testing; twentieth informational supplement. Vol. 30. Wayne : Pennsylvania( USA. ), 2010 : M100- S19.
9Pach6n-Ib6fiez ME, Jim6nez-Mejias ME, Pichardo C, et al. Activity of tigecycline ( GAR-936 ) against Acinetobacter baumannii strains, including those resistant to imipenem. Antimicrob Agents Chemother, 2004,48:4479-4481.
10American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital- acquired, ventilator-associated, and pneumonia. Am J Respir Crit Care Med, 2005,171:388-416.
3Gavin JR,Alberti K,Davidson MB,et aI.Eeport of the expert committee on the diagnosis and classification of diabetes mellitus[J].Diabetescare, 1997,20(7): 1183 -1197.
